U.S. Hemophilia Treatment Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (undefined)

U.S. Hemophilia Treatment Market is Segmented By Product Type (Recombinant Coagulation Factor, Plasma Derived Coagulation Factor, Antifibrinolytic Agents, and Others), By Disease Type (Hemophilia A, Hemophilia B, and Hemophilia C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies). The report offers the value (in USD billion) for the above-mentioned segments.

U.S. Hemophilia Treatment Market Leaders

  • Takeda Pharmaceutical Company Limited
  • Sanofi Octapharma AG
  • Swedish Orphan Biovitrum AB
  • Baxter International Inc.
  • Biogen Inc.
*Disclaimer: Major players are listed in no particular order.

U.S. Hemophilia Treatment Market - Company List

  • Takeda Pharmaceutical Company Limited
  • Sanofi Octapharma AG
  • Swedish Orphan Biovitrum AB
  • Baxter International Inc.
  • Biogen Inc.
  • Bayer AG
  • CSL Behring
  • Ferring B.V.
  • Pfizer, Inc.
  • Kedrion
  • Novo Nordisk A/S
  • Grifols S.A.
  • Sangamo Therapeutics, Inc.
  • Spark Therapeutics, Inc.

U.S. Hemophilia Treatment Market Report Snapshots

Buy Now